Khiron Life Sciences Corp. announced the addition of Dr. Eduardo Faveret, as Medical Director for Zerenia™ Brazil. As the company expands its global leadership position, the addition of Dr. Faveret represents a major milestone toward bringing the company’s market validated clinic strategy to larger markets in Latin America. Dr. Faveret is a prominent advocate for medical cannabis in Brazil and a prescriber in the country of more than 200 million people. In 2013, Dr. Faveret became one of the first physicians in Brazil to prescribe medical cannabis extract to a child, subsequently treating more than 3,000 patients with conditions such as Alzheimer's, Parkinson's, MS, cancer, anxiety, depression, insomnia, Tourette's syndrome, autism, and chronic pain, among others. Dr. Faveret boasts a highly distinguished medical and academic career, as the founder and former medical director of the Epilepsy Center at the Paulo Niemeyer State Brain Institute in Rio de Janeiro.